Sacerdote de Lustig E - Search Results

1

Characterization of a fibroblastoid mammary carcinoma cell line (LM2) originated from a mouse adenocarcinoma.

Galli S, Colombo L, Vanzuli S, Daroqui MC, del Carmen Vidal M, Jasnis MA, Sacerdote de Lustig E, Eijan AM. Galli S, et al. Among authors: sacerdote de lustig e. Int J Oncol. 2000 Dec;17(6):1259-65. doi: 10.3892/ijo.17.6.1259. Int J Oncol. 2000. PMID: 11078814

2

Nitric oxide synthase, arginase and cyclooxygenase are involved in muscarinic receptor activation in different murine mammary adenocarcinoma cell lines.

Español A, Eiján AM, Mazzoni E, Davel L, Jasnis MA, Sacerdote De Lustig E, Sales ME. Español A, et al. Among authors: sacerdote de lustig e. Int J Mol Med. 2002 Jun;9(6):651-7. Int J Mol Med. 2002. PMID: 12011984

3

Nitric oxide in patients with transitional bladder cancer.

Eiján AM, Piccardo I, Riveros MD, Sandes EO, Porcella H, Jasnis MA, Sacerdote De Lustig E, Malagrino H, Pasik L, Casabé AR. Eiján AM, et al. Among authors: sacerdote de lustig e. J Surg Oncol. 2002 Dec;81(4):203-8. doi: 10.1002/jso.10170. J Surg Oncol. 2002. PMID: 12451625

4

Heparin receptors in two murine mammary adenocarcinomas with different metastatic ability: relationship with growth inhibition.

Esteban Bertolesi G, Lauría de Cidre L, Sacerdote de Lustig E, Eiján AM. Esteban Bertolesi G, et al. Among authors: sacerdote de lustig e. Cancer Lett. 1995 Apr 14;90(2):123-31. doi: 10.1016/0304-3835(95)03693-q. Cancer Lett. 1995. PMID: 7736447

5

Influence of mast cells on two murine mammary adenocarcinomas.

de Cidre LL, Eijan AM, Bertolesi G, Isturiz M, Sacerdote de Lustig E. de Cidre LL, et al. Among authors: sacerdote de lustig e. Tumour Biol. 1996;17(6):345-53. doi: 10.1159/000217999. Tumour Biol. 1996. PMID: 8938950

6

Angiogenic activity by spleen cell supernatants from tumor-bearing and tumor-resected mice.

Davel L, Miguez M, Jasnis MA, Eiján AM, Oisgold-Dagá S, Sacerdote de Lustig E. Davel L, et al. Among authors: sacerdote de lustig e. J Surg Oncol. 1988 Jan;37(1):44-8. doi: 10.1002/jso.2930370113. J Surg Oncol. 1988. PMID: 2447442

7

Polyamines prevent DFMO-mediated inhibition of angiogenesis.

Jasnis MA, Klein S, Monte M, Davel L, Sacerdote de Lustig E, Algranati ID. Jasnis MA, et al. Among authors: sacerdote de lustig e. Cancer Lett. 1994 Apr 29;79(1):39-43. doi: 10.1016/0304-3835(94)90060-4. Cancer Lett. 1994. PMID: 7514492

8

Muscarinic receptors autoantibodies purified from mammary adenocarcinoma-bearing mice sera stimulate tumor progression.

Fiszman G, Cattaneo V, de la Torre E, Español A, Colombo L, Sacerdote de Lustig E, Sales ME. Fiszman G, et al. Among authors: sacerdote de lustig e. Int Immunopharmacol. 2006 Aug;6(8):1323-30. doi: 10.1016/j.intimp.2006.04.007. Epub 2006 May 15. Int Immunopharmacol. 2006. PMID: 16782546

9

Arginine metabolic pathways involved in the modulation of tumor-induced angiogenesis by macrophages.

Davel LE, Jasnis MA, de la Torre E, Gotoh T, Diament M, Magenta G, Sacerdote de Lustig E, Sales ME. Davel LE, et al. Among authors: sacerdote de lustig e. FEBS Lett. 2002 Dec 4;532(1-2):216-20. doi: 10.1016/s0014-5793(02)03682-7. FEBS Lett. 2002. PMID: 12459493 Free article.

10

Soluble factors from the target organ enhance tumor cell angiogenesis: role of laminin SIKVAV sequence.

Davel LE, Puricelli LI, Del Carmen C Vidal M, De Lorenzo MS, Sacerdote de Lustig E, Bal de Kier Joffe ED. Davel LE, et al. Among authors: sacerdote de lustig e, de lorenzo ms. Oncol Rep. 1999 Jul-Aug;6(4):907-11. doi: 10.3892/or.6.4.907. Oncol Rep. 1999. PMID: 10373680

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

57 results

Search Page

Filters